Viiv Healthcare starts phase III trial for two-drug regimen of dolutegravir/lamivudine Aug. 18, 2016 No Comments
ANXA1 signaling as a novel therapeutic target for the resolution of immune dysfunction in HIV Aug. 11, 2016 No Comments
Janssen files for approval of darunavir/cobicistat combination tablets in Japan July 29, 2016 No Comments
Novel bispecific immunoadhesin shows promise for HIV prevention and immunotherapy July 26, 2016 No Comments
Targeting Tat expression pathways may be useful for reactivation of latent HIV-1 July 26, 2016 No Comments
EMA's CHMP adopts positive opinion on type II variation application for Gilead's Truvada July 25, 2016 No Comments
ABX-464 well tolerated in first study in HIV-infected patients, another under way July 22, 2016 No Comments
RSS